Survival after radical cystectomy during holiday periods Show others and affiliations
2021 (English) In: Scandinavian journal of urology, ISSN 2168-1805, E-ISSN 2168-1813, Vol. 55, no 4, p. 276-280Article in journal (Refereed) Published
Abstract [en]
OBJECTIVE: For patients undergoing radical cystectomy for bladder cancer, a procedure requiring complex urinary tract reconstruction prone to major postoperative complications, the timing and quality of the surgery have been associated with outcomes.
PATIENTS AND METHODS: This study investigated if radical cystectomy for bladder cancer performed during holiday periods had worse disease-specific (DSS) and overall survival (OS), higher 90-day mortality and risk of readmissions. All patients operated on with radical cystectomy for primary bladder cancer during 1997-2014 with holiday periods as exposure (with one narrow (7 weeks) and one wider (14 weeks) definition) in the Swedish population-based bladder cancer research-database (BladderBaSe) were studied. DSS and OS after radical cystectomy during holiday periods were analysed with Cox regression models adjusted for sex, age, comorbidity, marital status, T-stage and nodal metastases, neoadjuvant chemotherapy, hospital volume and year of cystectomy.
RESULTS: Surgery during the holiday periods (narrow and wide definitions) were not associated with DSS (Hazard ratio [HR] = 1.05, 95% confidence interval [95% CI] = 0.90-1.21 and HR = 1.04, 95% CI = 0.91-1.17), respectively. HRs for OS were similar, and no associations between radical cystectomy during any of the holiday period definitions and 90-day mortality and readmission were found.
CONCLUSION: Survival after radical cystectomy in Sweden is similar during holiday and non-holiday periods.
Place, publisher, year, edition, pages Taylor & Francis, 2021. Vol. 55, no 4, p. 276-280
Keywords [en]
Bladder cancer, holiday periods, radical cystectomy, survival
National Category
Cancer and Oncology Clinical Medicine
Identifiers URN: urn:nbn:se:oru:diva-92369 DOI: 10.1080/21681805.2021.1938665 ISI: 000661345900001 PubMedID: 34124994 Scopus ID: 2-s2.0-85107846587 OAI: oai:DiVA.org:oru-92369 DiVA, id: diva2:1566411
Funder Swedish Cancer Society, CAN 2019/62 CAN 2017/278
Note Funding Agencies:
Lund Medical Faculty (ALF)
Skåne University Hospital Research Funds
Gyllenstierna Krapperup s Foundation
Skåne County Council's Research and Development Foundation REGSKANE-622351
Gösta Jonsson Research Foundation
Foundation of Urological Research
Hillevi Fries Research Foundation
2021-06-152021-06-152025-02-18 Bibliographically approved